I’m adding Hims & Hers Health ($HIMS) to my Red Flag Alerts...
The stock leaped to life last week after the telehealth platform known best for its erectile dysfunction and hair loss products announced it was adding a compounded GLP-1 weight-loss drug to its lineup.
The bull story is focused on strong margins and subscriber growth...
Beyond that, the model appears to be challenged, which is why I’m adding it to Red Flag Alerts.
In going over it with my friend Russell Young of Decameron Capital, who recently shorted the stock and is hoping to add more, here are some of the reasons, in no particular order...
You need to have a subscription to access this content in full.
Log in or subscribe today to unlock new features and receive Member Benefits.